Musculoskeletal
Cervical Lesion
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Cervical Lesion is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
10
clinical trials
Completed5 · 50%
Unknown status3 · 30%
Recruiting1 · 10%
Terminated1 · 10%
Clinical Trials
Trial Activity
10 trials
Bioactive Glass Air-abrasion and Non-carious Cervical Lesions
Completed·—·N/A·NCT04578717·15 enrolled
Topical Curcumin for Precancer Cervical Lesions
Terminated·—·Phase 2·NCT02944578·7 enrolled
Evaluation of Glass Ionomer With Advanced Glass Hybrid Technology Versus Resin Modified Glass Ionomer in Adult Patients With Carious Cervical Lesions After One Year
Unknown status·—·N/A·NCT05617703·22 enrolled
Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions
Unknown status·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 2·NCT04211103·45 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)